Dear, it is a well-known company in the industry. Zhongyuan Huiji Biotechnology Co., Ltd. is a high-tech enterprise specializing in the research and development, production, sales and technical services of in vitro diagnostic reagents and instruments. , the company’s headquarters building and manufacturing center are located in Dadukou District, Chongqing. Zhongyuan Huiji has more than 3,200 employees worldwide, of which R&D and technical service personnel account for nearly 1/2 of the total number. Among R&D personnel, nearly 50% have a master's degree or above. The company plans to invest in R&D annually as a proportion of sales revenue. Not less than 15. As a postdoctoral scientific research workstation, Zhongyuan Huiji continues to help promote the transformation of scientific research results, and has established a research and development system centered in Chongqing and radiating to Beijing, Shanghai, Guangzhou, Shenzhen, Nanjing and Xiamen. Zhongyuan Huiji focuses deeply on cutting-edge in vitro diagnostic technology and regards research and development as the core driving force for the sustainable development of the company. The company's main business covers biochemistry, immunity, molecules, POCT, clinical examination, microbiology and pathology and other diagnostic products as well as upstream raw materials. The company has also made a comprehensive layout in core technical fields such as biological raw materials and chemical raw materials, and has genetically engineered antigens/antibodies, diagnostic nanomaterials, high-precision diagnostic instruments and core component development, multiple marker signal amplification, rapid nucleic acid extraction and detection and other core technologies. It has obtained nearly 50 invention patents and nearly 400 product registration certificates. In 2018, Zhongyuan Huiji officially established a standardized reference measurement laboratory, and some projects have passed the International Reference Laboratory Proficiency Verification (IFCC-RELA), the highest level of quality evaluation in the field of global clinical chemistry. Zhongyuan Huiji currently has a 66,000-square-meter production plant, equipped with qualified modern production workshops, and has 19 production lines for reagents and instruments. The production process is strictly operated in accordance with national unified standards and has passed ISO9001 and ISO13485 certification. The current annual production capacity can reach 2 billion reagents and 20,000 instruments.